Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26832368 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.26832368 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97574898 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.97574898 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.50894215 |
6 | indole-containing compound catabolic process (GO:0042436) | 5.86595119 |
7 | indolalkylamine catabolic process (GO:0046218) | 5.86595119 |
8 | tryptophan catabolic process (GO:0006569) | 5.86595119 |
9 | glyoxylate metabolic process (GO:0046487) | 5.81590804 |
10 | kynurenine metabolic process (GO:0070189) | 5.76888897 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.68842327 |
12 | bile acid biosynthetic process (GO:0006699) | 5.61611057 |
13 | tryptophan metabolic process (GO:0006568) | 5.56369424 |
14 | actin-myosin filament sliding (GO:0033275) | 5.43266603 |
15 | muscle filament sliding (GO:0030049) | 5.43266603 |
16 | cysteine metabolic process (GO:0006534) | 5.37183466 |
17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30181871 |
18 | sulfur amino acid catabolic process (GO:0000098) | 5.27048912 |
19 | epoxygenase P450 pathway (GO:0019373) | 5.25307336 |
20 | urea metabolic process (GO:0019627) | 5.21594500 |
21 | urea cycle (GO:0000050) | 5.21594500 |
22 | lysine catabolic process (GO:0006554) | 5.19675568 |
23 | lysine metabolic process (GO:0006553) | 5.19675568 |
24 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06085805 |
25 | serine family amino acid catabolic process (GO:0009071) | 4.96355743 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 4.92575221 |
27 | complement activation, alternative pathway (GO:0006957) | 4.92574300 |
28 | negative regulation of fibrinolysis (GO:0051918) | 4.88047754 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.82140403 |
30 | regulation of protein activation cascade (GO:2000257) | 4.82025039 |
31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.81655863 |
32 | protein carboxylation (GO:0018214) | 4.81655863 |
33 | homocysteine metabolic process (GO:0050667) | 4.78969238 |
34 | aromatic amino acid family metabolic process (GO:0009072) | 4.75567832 |
35 | creatine metabolic process (GO:0006600) | 4.74480083 |
36 | bile acid metabolic process (GO:0008206) | 4.73826536 |
37 | regulation of fibrinolysis (GO:0051917) | 4.71606636 |
38 | amino-acid betaine metabolic process (GO:0006577) | 4.70655093 |
39 | NADH metabolic process (GO:0006734) | 4.70027482 |
40 | regulation of triglyceride catabolic process (GO:0010896) | 4.64758769 |
41 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.63073851 |
42 | cellular ketone body metabolic process (GO:0046950) | 4.61057408 |
43 | alpha-amino acid catabolic process (GO:1901606) | 4.59680877 |
44 | actin-mediated cell contraction (GO:0070252) | 4.56515126 |
45 | tyrosine metabolic process (GO:0006570) | 4.53622654 |
46 | regulation of complement activation (GO:0030449) | 4.53130541 |
47 | reverse cholesterol transport (GO:0043691) | 4.33340639 |
48 | omega-hydroxylase P450 pathway (GO:0097267) | 4.32741487 |
49 | acylglycerol homeostasis (GO:0055090) | 4.31962755 |
50 | triglyceride homeostasis (GO:0070328) | 4.31962755 |
51 | cellular amino acid catabolic process (GO:0009063) | 4.31227299 |
52 | regulation of cholesterol esterification (GO:0010872) | 4.30559960 |
53 | coenzyme catabolic process (GO:0009109) | 4.29140835 |
54 | regulation of skeletal muscle contraction (GO:0014819) | 4.28718436 |
55 | protein-lipid complex remodeling (GO:0034368) | 4.26440717 |
56 | macromolecular complex remodeling (GO:0034367) | 4.26440717 |
57 | plasma lipoprotein particle remodeling (GO:0034369) | 4.26440717 |
58 | phenylpropanoid metabolic process (GO:0009698) | 4.20261659 |
59 | indolalkylamine metabolic process (GO:0006586) | 4.19540452 |
60 | glutamate metabolic process (GO:0006536) | 4.17532182 |
61 | ethanol oxidation (GO:0006069) | 4.16772983 |
62 | blood coagulation, intrinsic pathway (GO:0007597) | 4.12572953 |
63 | skeletal muscle contraction (GO:0003009) | 4.12265323 |
64 | cellular modified amino acid catabolic process (GO:0042219) | 4.10177207 |
65 | fructose metabolic process (GO:0006000) | 4.09922869 |
66 | short-chain fatty acid metabolic process (GO:0046459) | 4.09329392 |
67 | negative regulation of sterol transport (GO:0032372) | 4.06933182 |
68 | negative regulation of cholesterol transport (GO:0032375) | 4.06933182 |
69 | cellular glucuronidation (GO:0052695) | 4.06700232 |
70 | amine catabolic process (GO:0009310) | 4.04198313 |
71 | cellular biogenic amine catabolic process (GO:0042402) | 4.04198313 |
72 | phospholipid efflux (GO:0033700) | 4.03773384 |
73 | bile acid and bile salt transport (GO:0015721) | 4.03659436 |
74 | acetyl-CoA metabolic process (GO:0006084) | 4.01692988 |
75 | serine family amino acid metabolic process (GO:0009069) | 4.01616413 |
76 | glycine metabolic process (GO:0006544) | 4.01239537 |
77 | 2-oxoglutarate metabolic process (GO:0006103) | 3.99161945 |
78 | ketone body metabolic process (GO:1902224) | 3.98493379 |
79 | aspartate family amino acid catabolic process (GO:0009068) | 3.98129556 |
80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98032741 |
81 | benzene-containing compound metabolic process (GO:0042537) | 3.97650808 |
82 | drug metabolic process (GO:0017144) | 3.96603111 |
83 | plasma lipoprotein particle clearance (GO:0034381) | 3.95912482 |
84 | drug catabolic process (GO:0042737) | 3.92909281 |
85 | fatty acid beta-oxidation (GO:0006635) | 3.92651932 |
86 | ethanol metabolic process (GO:0006067) | 3.89416222 |
87 | oxaloacetate metabolic process (GO:0006107) | 3.89000164 |
88 | imidazole-containing compound metabolic process (GO:0052803) | 3.87566541 |
89 | * carboxylic acid catabolic process (GO:0046395) | 3.85769432 |
90 | * organic acid catabolic process (GO:0016054) | 3.85769432 |
91 | aldehyde catabolic process (GO:0046185) | 3.79230816 |
92 | oxidative demethylation (GO:0070989) | 3.75311825 |
93 | * fatty acid oxidation (GO:0019395) | 3.74694424 |
94 | arginine metabolic process (GO:0006525) | 3.73180906 |
95 | regulation of relaxation of muscle (GO:1901077) | 3.70881890 |
96 | cholesterol efflux (GO:0033344) | 3.70728313 |
97 | drug transmembrane transport (GO:0006855) | 3.70495218 |
98 | * monocarboxylic acid catabolic process (GO:0072329) | 3.68579926 |
99 | * lipid oxidation (GO:0034440) | 3.67685905 |
100 | serine family amino acid biosynthetic process (GO:0009070) | 3.66897644 |
101 | uronic acid metabolic process (GO:0006063) | 3.65833535 |
102 | glucuronate metabolic process (GO:0019585) | 3.65833535 |
103 | phospholipid homeostasis (GO:0055091) | 3.64675344 |
104 | * fatty acid catabolic process (GO:0009062) | 3.63591997 |
105 | tricarboxylic acid cycle (GO:0006099) | 3.62679154 |
106 | carnitine metabolic process (GO:0009437) | 3.60336307 |
107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60107230 |
108 | positive regulation of lipid catabolic process (GO:0050996) | 3.57407539 |
109 | exogenous drug catabolic process (GO:0042738) | 3.56311900 |
110 | urate metabolic process (GO:0046415) | 3.56121089 |
111 | valine metabolic process (GO:0006573) | 3.55830368 |
112 | cofactor catabolic process (GO:0051187) | 3.55177590 |
113 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51508543 |
114 | cytolysis (GO:0019835) | 3.50924538 |
115 | response to muscle activity (GO:0014850) | 3.50667343 |
116 | plasma lipoprotein particle assembly (GO:0034377) | 3.49959036 |
117 | regulation of cholesterol homeostasis (GO:2000188) | 3.49703481 |
118 | gluconeogenesis (GO:0006094) | 3.49315215 |
119 | fibrinolysis (GO:0042730) | 3.48855602 |
120 | flavonoid metabolic process (GO:0009812) | 3.48825363 |
121 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46970260 |
122 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.41843033 |
123 | regulation of plasminogen activation (GO:0010755) | 3.31732575 |
124 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.30341407 |
125 | glycogen catabolic process (GO:0005980) | 3.30041462 |
126 | branched-chain amino acid catabolic process (GO:0009083) | 3.27047609 |
127 | actin filament-based movement (GO:0030048) | 3.25834873 |
128 | xenobiotic catabolic process (GO:0042178) | 3.24654558 |
129 | branched-chain amino acid metabolic process (GO:0009081) | 3.24281899 |
130 | hexose biosynthetic process (GO:0019319) | 3.24028310 |
131 | response to mercury ion (GO:0046689) | 3.21518697 |
132 | myofibril assembly (GO:0030239) | 3.20970322 |
133 | regulation of sequestering of triglyceride (GO:0010889) | 3.18175409 |
134 | polyketide metabolic process (GO:0030638) | 3.17606996 |
135 | doxorubicin metabolic process (GO:0044598) | 3.17606996 |
136 | daunorubicin metabolic process (GO:0044597) | 3.17606996 |
137 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.16274782 |
138 | striated muscle contraction (GO:0006941) | 3.14844539 |
139 | negative regulation of hemostasis (GO:1900047) | 3.11690574 |
140 | negative regulation of blood coagulation (GO:0030195) | 3.11690574 |
141 | glucan catabolic process (GO:0009251) | 3.09375675 |
142 | arginine catabolic process (GO:0006527) | 3.08011049 |
143 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.06809218 |
144 | sarcomere organization (GO:0045214) | 3.01102019 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.94919108 |
2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.85621621 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.32826281 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.21481300 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.48965400 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.09016422 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.65452342 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95336364 |
9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.82719573 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59542682 |
11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.50299638 |
12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06652822 |
13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05485865 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2858761 |
15 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.98748022 |
16 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98255790 |
17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69699566 |
18 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60493881 |
19 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57434412 |
20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.54795276 |
21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.46365864 |
22 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44880177 |
23 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.43458666 |
24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38956661 |
25 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.37987398 |
26 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.35996191 |
27 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33398095 |
28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33281678 |
29 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33255703 |
30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.29760508 |
31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27664372 |
32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25901972 |
33 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.24263554 |
34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22497171 |
35 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.20731884 |
36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16573637 |
37 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.15962062 |
38 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.14036868 |
39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13750412 |
40 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.13721997 |
41 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.12480766 |
42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12000596 |
43 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.11108742 |
44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10346294 |
45 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.09329791 |
46 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08722732 |
47 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08248928 |
48 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.08107463 |
49 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.07877661 |
50 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07839043 |
51 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07839043 |
52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07253716 |
53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.06937542 |
54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02809722 |
55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02194659 |
56 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02036729 |
57 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00095932 |
58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.99335337 |
59 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.98589824 |
60 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97430176 |
61 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.96359614 |
62 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.96208619 |
63 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96180929 |
64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.95995436 |
65 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95104312 |
66 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94727618 |
67 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94558243 |
68 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92829119 |
69 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91706404 |
70 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91587774 |
71 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.91308940 |
72 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.90321949 |
73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88090887 |
74 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87269826 |
75 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87073833 |
76 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86057182 |
77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.85925069 |
78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.85258831 |
79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.84991692 |
80 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.84514882 |
81 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84467307 |
82 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84150320 |
83 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82845959 |
84 | NFYB_21822215_ChIP-Seq_K562_Human | 0.82805127 |
85 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.82069645 |
86 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.81699627 |
87 | NFYA_21822215_ChIP-Seq_K562_Human | 0.81670973 |
88 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80889937 |
89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.80674992 |
90 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.79869601 |
91 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.79690342 |
92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.77399203 |
93 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.76638109 |
94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.76608326 |
95 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.76299314 |
96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76105631 |
97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76105631 |
98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.75907858 |
99 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72717885 |
100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.72498772 |
101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.71139475 |
102 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.70943474 |
103 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69780542 |
104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69492977 |
105 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68342196 |
106 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67734833 |
107 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.66945597 |
108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66519283 |
109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65846405 |
110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65380989 |
111 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65183360 |
112 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64971274 |
113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63028065 |
114 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62795733 |
115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.62154168 |
116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.62123599 |
117 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62074652 |
118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61773415 |
119 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.59260881 |
120 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.57697159 |
121 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.57697159 |
122 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57669580 |
123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56417855 |
124 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56113130 |
125 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.55407582 |
126 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54918071 |
127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53031576 |
128 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52924807 |
129 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52916591 |
130 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.52021383 |
131 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51441705 |
132 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.51095672 |
133 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.50673612 |
134 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49640701 |
135 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49551613 |
136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49465918 |
137 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.49441586 |
138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.49058351 |
139 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47564446 |
140 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.47323804 |
141 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.47199817 |
142 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.47061148 |
143 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47000415 |
144 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46281165 |
145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.45680637 |
146 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.44784069 |
147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.44663326 |
148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.44599810 |
149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.44298335 |
150 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.44283641 |
151 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42800261 |
152 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.42136566 |
153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41523600 |
154 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.41451209 |
155 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.41294166 |
156 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.40475014 |
157 | NCOR_22424771_ChIP-Seq_293T_Human | 0.40026195 |
158 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39606371 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.90427487 |
2 | MP0005360_urolithiasis | 7.31432123 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.16790701 |
4 | MP0005365_abnormal_bile_salt | 5.94045818 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92792004 |
6 | MP0003806_abnormal_nucleotide_metabolis | 4.13792764 |
7 | MP0004145_abnormal_muscle_electrophysio | 3.88732993 |
8 | MP0003252_abnormal_bile_duct | 3.82294251 |
9 | MP0000751_myopathy | 3.64295596 |
10 | MP0010329_abnormal_lipoprotein_level | 3.40863280 |
11 | MP0000749_muscle_degeneration | 3.25738780 |
12 | MP0003195_calcinosis | 3.04982984 |
13 | MP0005332_abnormal_amino_acid | 3.02417022 |
14 | MP0009840_abnormal_foam_cell | 3.00156003 |
15 | MP0005083_abnormal_biliary_tract | 2.76588240 |
16 | MP0001666_abnormal_nutrient_absorption | 2.61233501 |
17 | MP0004019_abnormal_vitamin_homeostasis | 2.25368194 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.16914622 |
19 | * MP0002118_abnormal_lipid_homeostasis | 2.10939456 |
20 | MP0002138_abnormal_hepatobiliary_system | 2.10249151 |
21 | MP0002106_abnormal_muscle_physiology | 2.06219454 |
22 | * MP0000609_abnormal_liver_physiology | 2.05806327 |
23 | MP0000747_muscle_weakness | 2.02858504 |
24 | MP0004087_abnormal_muscle_fiber | 1.90382645 |
25 | * MP0005319_abnormal_enzyme/_coenzyme | 1.87265816 |
26 | MP0003868_abnormal_feces_composition | 1.79324513 |
27 | MP0005369_muscle_phenotype | 1.76224734 |
28 | MP0005620_abnormal_muscle_contractility | 1.73896057 |
29 | MP0000759_abnormal_skeletal_muscle | 1.71030274 |
30 | MP0001764_abnormal_homeostasis | 1.69618661 |
31 | MP0004084_abnormal_cardiac_muscle | 1.68116179 |
32 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66787295 |
33 | MP0002837_dystrophic_cardiac_calcinosis | 1.56466720 |
34 | MP0004215_abnormal_myocardial_fiber | 1.56014515 |
35 | MP0009643_abnormal_urine_homeostasis | 1.54742158 |
36 | MP0002972_abnormal_cardiac_muscle | 1.47426220 |
37 | MP0004233_abnormal_muscle_weight | 1.40898828 |
38 | MP0003186_abnormal_redox_activity | 1.39325103 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.38437908 |
40 | MP0009697_abnormal_copulation | 1.37570292 |
41 | MP0005451_abnormal_body_composition | 1.33956550 |
42 | MP0006036_abnormal_mitochondrial_physio | 1.29074876 |
43 | MP0000750_abnormal_muscle_regeneration | 1.27019066 |
44 | MP0000013_abnormal_adipose_tissue | 1.26360245 |
45 | MP0005670_abnormal_white_adipose | 1.23509706 |
46 | MP0004130_abnormal_muscle_cell | 1.18094947 |
47 | MP0005636_abnormal_mineral_homeostasis | 1.15582281 |
48 | MP0003011_delayed_dark_adaptation | 1.12434236 |
49 | MP0003656_abnormal_erythrocyte_physiolo | 1.10851167 |
50 | MP0005385_cardiovascular_system_phenoty | 1.08341485 |
51 | MP0001544_abnormal_cardiovascular_syste | 1.08341485 |
52 | * MP0000598_abnormal_liver_morphology | 1.07243214 |
53 | MP0005647_abnormal_sex_gland | 1.04356042 |
54 | MP0004484_altered_response_of | 1.04107505 |
55 | MP0002108_abnormal_muscle_morphology | 1.00918801 |
56 | MP0009764_decreased_sensitivity_to | 1.00106949 |
57 | MP0004043_abnormal_pH_regulation | 0.99644503 |
58 | MP0002876_abnormal_thyroid_physiology | 0.99499755 |
59 | MP0002078_abnormal_glucose_homeostasis | 0.99014909 |
60 | MP0002127_abnormal_cardiovascular_syste | 0.96611758 |
61 | MP0000604_amyloidosis | 0.96562367 |
62 | MP0005535_abnormal_body_temperature | 0.94999272 |
63 | MP0003705_abnormal_hypodermis_morpholog | 0.94130449 |
64 | MP0009763_increased_sensitivity_to | 0.91586583 |
65 | MP0002971_abnormal_brown_adipose | 0.90444398 |
66 | * MP0009642_abnormal_blood_homeostasis | 0.90113030 |
67 | MP0001756_abnormal_urination | 0.90088907 |
68 | MP0000003_abnormal_adipose_tissue | 0.87389538 |
69 | MP0005084_abnormal_gallbladder_morpholo | 0.87021824 |
70 | MP0008775_abnormal_heart_ventricle | 0.86056941 |
71 | MP0002254_reproductive_system_inflammat | 0.83723632 |
72 | MP0003879_abnormal_hair_cell | 0.83512140 |
73 | MP0006138_congestive_heart_failure | 0.83256037 |
74 | * MP0008469_abnormal_protein_level | 0.82863677 |
75 | MP0005187_abnormal_penis_morphology | 0.82672222 |
76 | MP0005376_homeostasis/metabolism_phenot | 0.82625651 |
77 | MP0010368_abnormal_lymphatic_system | 0.81534809 |
78 | MP0010630_abnormal_cardiac_muscle | 0.80682330 |
79 | MP0006035_abnormal_mitochondrial_morpho | 0.79808124 |
80 | MP0005220_abnormal_exocrine_pancreas | 0.79290109 |
81 | MP0005334_abnormal_fat_pad | 0.79192646 |
82 | MP0005266_abnormal_metabolism | 0.79125668 |
83 | MP0004270_analgesia | 0.78750731 |
84 | MP0005666_abnormal_adipose_tissue | 0.75516535 |
85 | MP0003137_abnormal_impulse_conducting | 0.74714675 |
86 | MP0005408_hypopigmentation | 0.74041821 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.69313969 |
88 | MP0001661_extended_life_span | 0.69090538 |
89 | MP0003329_amyloid_beta_deposits | 0.67120549 |
90 | MP0004085_abnormal_heartbeat | 0.66168694 |
91 | MP0002638_abnormal_pupillary_reflex | 0.66157280 |
92 | MP0003646_muscle_fatigue | 0.63019373 |
93 | MP0005448_abnormal_energy_balance | 0.61616616 |
94 | MP0002136_abnormal_kidney_physiology | 0.61236542 |
95 | MP0004147_increased_porphyrin_level | 0.60989723 |
96 | MP0003950_abnormal_plasma_membrane | 0.60423283 |
97 | MP0005330_cardiomyopathy | 0.60338568 |
98 | MP0000230_abnormal_systemic_arterial | 0.59581433 |
99 | MP0002822_catalepsy | 0.56129249 |
100 | MP0001765_abnormal_ion_homeostasis | 0.55823101 |
101 | MP0005379_endocrine/exocrine_gland_phen | 0.54733951 |
102 | MP0003953_abnormal_hormone_level | 0.54243246 |
103 | MP0002090_abnormal_vision | 0.54086793 |
104 | MP0000733_abnormal_muscle_development | 0.53875192 |
105 | MP0002938_white_spotting | 0.53447315 |
106 | MP0005058_abnormal_lysosome_morphology | 0.52889110 |
107 | MP0010386_abnormal_urinary_bladder | 0.50196414 |
108 | MP0000639_abnormal_adrenal_gland | 0.49095668 |
109 | MP0002928_abnormal_bile_duct | 0.48236318 |
110 | MP0003638_abnormal_response/metabolism_ | 0.47916821 |
111 | MP0001984_abnormal_olfaction | 0.47725204 |
112 | MP0003122_maternal_imprinting | 0.47155007 |
113 | MP0004510_myositis | 0.46015573 |
114 | MP0002269_muscular_atrophy | 0.45987898 |
115 | MP0003941_abnormal_skin_development | 0.45248184 |
116 | MP0000372_irregular_coat_pigmentation | 0.44799324 |
117 | MP0008874_decreased_physiological_sensi | 0.43665189 |
118 | MP0005395_other_phenotype | 0.42311199 |
119 | MP0004036_abnormal_muscle_relaxation | 0.39734226 |
120 | MP0003724_increased_susceptibility_to | 0.39463931 |
121 | MP0009115_abnormal_fat_cell | 0.39114631 |
122 | MP0004782_abnormal_surfactant_physiolog | 0.39074931 |
123 | MP0008872_abnormal_physiological_respon | 0.38202129 |
124 | MP0008873_increased_physiological_sensi | 0.36773049 |
125 | MP0003075_altered_response_to | 0.36440736 |
126 | MP0009053_abnormal_anal_canal | 0.36199500 |
127 | MP0005166_decreased_susceptibility_to | 0.35938306 |
128 | MP0005375_adipose_tissue_phenotype | 0.34644051 |
129 | MP0002168_other_aberrant_phenotype | 0.34573348 |
130 | MP0009384_cardiac_valve_regurgitation | 0.34525775 |
131 | MP0000579_abnormal_nail_morphology | 0.33203190 |
132 | MP0003959_abnormal_lean_body | 0.32657622 |
133 | MP0001944_abnormal_pancreas_morphology | 0.32517312 |
134 | * MP0003690_abnormal_glial_cell | 0.31757128 |
135 | MP0000538_abnormal_urinary_bladder | 0.30788257 |
136 | MP0003718_maternal_effect | 0.29775153 |
137 | * MP0002970_abnormal_white_adipose | 0.29090808 |
138 | MP0009672_abnormal_birth_weight | 0.29043378 |
139 | MP0002796_impaired_skin_barrier | 0.28975753 |
140 | MP0000249_abnormal_blood_vessel | 0.28230116 |
141 | MP0002332_abnormal_exercise_endurance | 0.28122475 |
142 | MP0005165_increased_susceptibility_to | 0.27887235 |
143 | MP0005464_abnormal_platelet_physiology | 0.27874737 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 7.51228500 |
2 | Nemaline bodies (HP:0003798) | 7.35845944 |
3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 7.12094399 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.87630751 |
5 | Intrahepatic cholestasis (HP:0001406) | 6.64236331 |
6 | Deep venous thrombosis (HP:0002625) | 6.32840459 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92809961 |
8 | Exercise-induced muscle cramps (HP:0003710) | 5.82160035 |
9 | Xanthomatosis (HP:0000991) | 5.78174690 |
10 | Exercise-induced myalgia (HP:0003738) | 5.70058693 |
11 | Prolonged partial thromboplastin time (HP:0003645) | 5.68579983 |
12 | Hypobetalipoproteinemia (HP:0003563) | 5.56942113 |
13 | Type 1 muscle fiber predominance (HP:0003803) | 5.32391851 |
14 | Hyperlipoproteinemia (HP:0010980) | 4.99459637 |
15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.90372384 |
16 | Complement deficiency (HP:0004431) | 4.86846602 |
17 | Hyperammonemia (HP:0001987) | 4.75794550 |
18 | Ketosis (HP:0001946) | 4.67559232 |
19 | Hyperglycinemia (HP:0002154) | 4.52849934 |
20 | Hyperglycinuria (HP:0003108) | 4.51733840 |
21 | Calf muscle hypertrophy (HP:0008981) | 4.47369274 |
22 | Hypoglycemic coma (HP:0001325) | 4.43007487 |
23 | Hypolipoproteinemia (HP:0010981) | 4.32697521 |
24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.29915993 |
25 | Abnormality of glycine metabolism (HP:0010895) | 4.29915993 |
26 | Rhabdomyolysis (HP:0003201) | 4.25272473 |
27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20258721 |
28 | Epidermoid cyst (HP:0200040) | 4.09895204 |
29 | Joint hemorrhage (HP:0005261) | 4.08874777 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.98995043 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.96424144 |
32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96385357 |
33 | Distal arthrogryposis (HP:0005684) | 3.92972198 |
34 | Abnormality of the common coagulation pathway (HP:0010990) | 3.91416838 |
35 | Hypoalphalipoproteinemia (HP:0003233) | 3.90880650 |
36 | EMG: myopathic abnormalities (HP:0003458) | 3.85774830 |
37 | Abnormality of methionine metabolism (HP:0010901) | 3.81081651 |
38 | Ketoacidosis (HP:0001993) | 3.80375615 |
39 | Fat malabsorption (HP:0002630) | 3.77025103 |
40 | * Abnormality of fatty-acid metabolism (HP:0004359) | 3.60140556 |
41 | Abnormality of the calf musculature (HP:0001430) | 3.59836806 |
42 | Myopathic facies (HP:0002058) | 3.53574854 |
43 | Conjugated hyperbilirubinemia (HP:0002908) | 3.53193760 |
44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.51182460 |
45 | Abnormality of complement system (HP:0005339) | 3.46091542 |
46 | Hyporeflexia of lower limbs (HP:0002600) | 3.37663042 |
47 | Rimmed vacuoles (HP:0003805) | 3.27332252 |
48 | Muscle fiber splitting (HP:0003555) | 3.25244071 |
49 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.25071231 |
50 | Dicarboxylic aciduria (HP:0003215) | 3.17829690 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.17829690 |
52 | Abnormality of serum amino acid levels (HP:0003112) | 3.16845545 |
53 | Round ear (HP:0100830) | 3.16333982 |
54 | Hypercholesterolemia (HP:0003124) | 3.15919523 |
55 | Gout (HP:0001997) | 3.15626757 |
56 | Hyperbilirubinemia (HP:0002904) | 3.15584417 |
57 | Abnormality of nucleobase metabolism (HP:0010932) | 3.09261787 |
58 | Metabolic acidosis (HP:0001942) | 3.08858125 |
59 | Asymmetric septal hypertrophy (HP:0001670) | 3.03488063 |
60 | Delayed CNS myelination (HP:0002188) | 3.03470208 |
61 | Abnormality of purine metabolism (HP:0004352) | 3.01357064 |
62 | Ulnar deviation of the wrist (HP:0003049) | 2.98185845 |
63 | Lethargy (HP:0001254) | 2.95977108 |
64 | Cerebral edema (HP:0002181) | 2.94100877 |
65 | Neck muscle weakness (HP:0000467) | 2.93488314 |
66 | * Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.92178327 |
67 | Generalized aminoaciduria (HP:0002909) | 2.83518258 |
68 | Steatorrhea (HP:0002570) | 2.78848359 |
69 | Skin nodule (HP:0200036) | 2.77014047 |
70 | Hypoglycemic seizures (HP:0002173) | 2.73794873 |
71 | Hepatocellular carcinoma (HP:0001402) | 2.69846124 |
72 | Sudden death (HP:0001699) | 2.67382080 |
73 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.62844668 |
74 | Muscle stiffness (HP:0003552) | 2.62769934 |
75 | Bundle branch block (HP:0011710) | 2.62426453 |
76 | Increased serum pyruvate (HP:0003542) | 2.57169728 |
77 | Reduced antithrombin III activity (HP:0001976) | 2.56818622 |
78 | Difficulty running (HP:0009046) | 2.53533243 |
79 | Systemic lupus erythematosus (HP:0002725) | 2.52032424 |
80 | Vascular calcification (HP:0004934) | 2.51635632 |
81 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51493391 |
82 | Absent phalangeal crease (HP:0006109) | 2.50537902 |
83 | Spontaneous abortion (HP:0005268) | 2.50389487 |
84 | Myocardial infarction (HP:0001658) | 2.49109815 |
85 | Abnormal gallbladder morphology (HP:0012437) | 2.47205100 |
86 | Distal lower limb muscle weakness (HP:0009053) | 2.46254954 |
87 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.45202284 |
88 | Subaortic stenosis (HP:0001682) | 2.45202284 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.44246100 |
90 | Abnormality of glycolysis (HP:0004366) | 2.42384943 |
91 | Vomiting (HP:0002013) | 2.41524359 |
92 | Cholelithiasis (HP:0001081) | 2.41023978 |
93 | Late onset (HP:0003584) | 2.39048453 |
94 | Proximal tubulopathy (HP:0000114) | 2.38488745 |
95 | Irritability (HP:0000737) | 2.38389563 |
96 | Hypochromic microcytic anemia (HP:0004840) | 2.36368903 |
97 | Neonatal onset (HP:0003623) | 2.35416314 |
98 | Acute necrotizing encephalopathy (HP:0006965) | 2.32389295 |
99 | Calcaneovalgus deformity (HP:0001848) | 2.30040832 |
100 | Malnutrition (HP:0004395) | 2.24916547 |
101 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.23932966 |
102 | Spastic diplegia (HP:0001264) | 2.23109424 |
103 | Cholecystitis (HP:0001082) | 2.22736088 |
104 | Abnormal gallbladder physiology (HP:0012438) | 2.22736088 |
105 | Pancreatitis (HP:0001733) | 2.21967843 |
106 | Cardiovascular calcification (HP:0011915) | 2.21721075 |
107 | Increased purine levels (HP:0004368) | 2.19641474 |
108 | Hyperuricemia (HP:0002149) | 2.19641474 |
109 | Dilated cardiomyopathy (HP:0001644) | 2.19596875 |
110 | Alkalosis (HP:0001948) | 2.19071696 |
111 | Abnormality of urine glucose concentration (HP:0011016) | 2.16727031 |
112 | Glycosuria (HP:0003076) | 2.16727031 |
113 | Myoglobinuria (HP:0002913) | 2.16706157 |
114 | Acanthocytosis (HP:0001927) | 2.15226530 |
115 | Enlarged kidneys (HP:0000105) | 2.14884806 |
116 | Exercise intolerance (HP:0003546) | 2.14078415 |
117 | Myotonia (HP:0002486) | 2.12059860 |
118 | Hydroxyprolinuria (HP:0003080) | 2.11528629 |
119 | Abnormality of proline metabolism (HP:0010907) | 2.11528629 |
120 | Renal cortical cysts (HP:0000803) | 2.10824133 |
121 | Heart block (HP:0012722) | 2.10662602 |
122 | Mitral stenosis (HP:0001718) | 2.09036507 |
123 | Deformed tarsal bones (HP:0008119) | 2.08763437 |
124 | Brushfield spots (HP:0001088) | 2.08480491 |
125 | Frequent falls (HP:0002359) | 2.08070911 |
126 | Increased variability in muscle fiber diameter (HP:0003557) | 2.07607280 |
127 | Increased connective tissue (HP:0009025) | 2.06853982 |
128 | Hyperglycemia (HP:0003074) | 2.06723155 |
129 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03980265 |
130 | Areflexia of lower limbs (HP:0002522) | 2.03057650 |
131 | Progressive macrocephaly (HP:0004481) | 2.00906302 |
132 | Glomerulonephritis (HP:0000099) | 2.00856688 |
133 | Hepatocellular necrosis (HP:0001404) | 1.97841972 |
134 | Abnormality of the gallbladder (HP:0005264) | 1.97822062 |
135 | Esophageal varix (HP:0002040) | 1.97570498 |
136 | EMG: neuropathic changes (HP:0003445) | 1.96879773 |
137 | Amyloidosis (HP:0011034) | 1.94725309 |
138 | Abnormal finger flexion creases (HP:0006143) | 1.94669087 |
139 | Symptomatic seizures (HP:0011145) | 1.93570250 |
140 | Abnormal atrioventricular conduction (HP:0005150) | 1.93426405 |
141 | Increased muscle lipid content (HP:0009058) | 1.91639219 |
142 | Malignant hyperthermia (HP:0002047) | 1.91199434 |
143 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90558456 |
144 | Mitochondrial inheritance (HP:0001427) | 1.90466582 |
145 | Abnormal cartilage morphology (HP:0002763) | 1.89870138 |
146 | Opisthotonus (HP:0002179) | 1.88979765 |
147 | Hepatic necrosis (HP:0002605) | 1.87941528 |
148 | Rickets (HP:0002748) | 1.87671765 |
149 | Acute hepatic failure (HP:0006554) | 1.85373996 |
150 | Nausea (HP:0002018) | 1.83389165 |
151 | Acute encephalopathy (HP:0006846) | 1.82397937 |
152 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82282000 |
153 | Abnormality of vitamin metabolism (HP:0100508) | 1.81034812 |
154 | Elevated hepatic transaminases (HP:0002910) | 1.79892586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 7.54481776 |
2 | ERN1 | 3.94495865 |
3 | FGFR4 | 3.65210488 |
4 | SIK1 | 3.50202117 |
5 | INSRR | 3.30916824 |
6 | TAOK3 | 2.65432840 |
7 | ERBB4 | 2.38365292 |
8 | MAP2K4 | 2.02780313 |
9 | TRIB3 | 2.01746352 |
10 | PKN2 | 1.99463840 |
11 | MST1R | 1.88647746 |
12 | PDK3 | 1.85815396 |
13 | PDK4 | 1.85815396 |
14 | PINK1 | 1.81306621 |
15 | PIK3CG | 1.78246146 |
16 | FLT3 | 1.76322285 |
17 | LIMK1 | 1.65600046 |
18 | ERBB3 | 1.65036928 |
19 | FRK | 1.63559358 |
20 | MAPK11 | 1.60349077 |
21 | MUSK | 1.51097336 |
22 | STK38L | 1.50720336 |
23 | LATS1 | 1.49588057 |
24 | WNK4 | 1.38186181 |
25 | MAP3K7 | 1.34820773 |
26 | TYK2 | 1.30319562 |
27 | NEK9 | 1.28760318 |
28 | MAP3K12 | 1.26240936 |
29 | MYLK | 1.24865442 |
30 | PRKAA2 | 1.22871720 |
31 | PTK6 | 1.22851813 |
32 | MAPKAPK3 | 1.22177926 |
33 | DAPK2 | 1.19195900 |
34 | PDK2 | 1.19078545 |
35 | ABL2 | 1.16661188 |
36 | MAP3K3 | 1.11862530 |
37 | MAPK15 | 1.11506475 |
38 | JAK2 | 1.05717114 |
39 | TIE1 | 1.04451583 |
40 | MAP2K3 | 1.02419279 |
41 | OBSCN | 0.99949855 |
42 | CAMK2D | 0.98188168 |
43 | LMTK2 | 0.94594566 |
44 | KDR | 0.94265512 |
45 | STK16 | 0.94028330 |
46 | NME1 | 0.91892584 |
47 | WNK3 | 0.89545307 |
48 | JAK1 | 0.88594678 |
49 | PRKAA1 | 0.88386847 |
50 | FER | 0.87691978 |
51 | TRPM7 | 0.85683736 |
52 | TBK1 | 0.83034275 |
53 | MAPK12 | 0.82268996 |
54 | EPHB1 | 0.81581997 |
55 | CAMK2G | 0.81443148 |
56 | PHKG2 | 0.80586534 |
57 | PHKG1 | 0.80586534 |
58 | TTN | 0.79435068 |
59 | IRAK3 | 0.78854831 |
60 | ACVR1B | 0.77555276 |
61 | PRKACG | 0.77448260 |
62 | SGK3 | 0.76075844 |
63 | NEK1 | 0.75809649 |
64 | PRKG1 | 0.74414204 |
65 | AKT3 | 0.74297408 |
66 | FGFR2 | 0.74246337 |
67 | PIK3CA | 0.73751153 |
68 | GRK6 | 0.71912817 |
69 | TESK1 | 0.70724492 |
70 | MAPK4 | 0.69994944 |
71 | PDPK1 | 0.69781137 |
72 | PRKCZ | 0.69053846 |
73 | MET | 0.68293909 |
74 | ERBB2 | 0.67239183 |
75 | EPHA3 | 0.67134190 |
76 | MAP3K14 | 0.65025083 |
77 | MAP2K6 | 0.64878820 |
78 | SGK2 | 0.64642840 |
79 | EIF2AK3 | 0.64223569 |
80 | CAMK1D | 0.63889508 |
81 | MAP4K2 | 0.62971566 |
82 | SGK223 | 0.62451596 |
83 | SGK494 | 0.62451596 |
84 | PAK3 | 0.59717898 |
85 | CASK | 0.59144902 |
86 | GSK3A | 0.57929032 |
87 | RIPK1 | 0.57577042 |
88 | VRK2 | 0.56884169 |
89 | CAMK2A | 0.56603068 |
90 | MAP3K11 | 0.56249981 |
91 | CSNK1G1 | 0.55389929 |
92 | DMPK | 0.54864252 |
93 | CCNB1 | 0.54573284 |
94 | STK24 | 0.54156383 |
95 | PRKD3 | 0.51053561 |
96 | PRKCE | 0.50812005 |
97 | MST4 | 0.50067270 |
98 | TNIK | 0.49209981 |
99 | TRIM28 | 0.49095149 |
100 | AKT2 | 0.48121036 |
101 | TGFBR2 | 0.47952760 |
102 | MAP2K1 | 0.47644135 |
103 | FGFR3 | 0.47565437 |
104 | DYRK1B | 0.47126424 |
105 | MOS | 0.46068783 |
106 | PDK1 | 0.45906322 |
107 | OXSR1 | 0.45755832 |
108 | MAP3K5 | 0.44945282 |
109 | CAMK2B | 0.44777689 |
110 | PRKCQ | 0.44042149 |
111 | MAP3K2 | 0.44012609 |
112 | ROCK1 | 0.43963516 |
113 | MAPK7 | 0.43448831 |
114 | PTK2 | 0.42804995 |
115 | PRKACB | 0.42180560 |
116 | BCR | 0.41373799 |
117 | CSNK1G2 | 0.41066834 |
118 | EPHB2 | 0.41032574 |
119 | PBK | 0.40605219 |
120 | STK38 | 0.40479092 |
121 | IRAK1 | 0.39943001 |
122 | CSNK1G3 | 0.38920442 |
123 | CSK | 0.38238612 |
124 | EIF2AK1 | 0.38131429 |
125 | PKN1 | 0.37891342 |
126 | CAMK1 | 0.37476660 |
127 | MAP3K1 | 0.36454216 |
128 | CAMK4 | 0.36094179 |
129 | RPS6KA3 | 0.33267558 |
130 | IGF1R | 0.33242591 |
131 | RET | 0.32770521 |
132 | EPHA4 | 0.31245674 |
133 | PRKD1 | 0.31237020 |
134 | NLK | 0.30330184 |
135 | PRKCG | 0.30222698 |
136 | BMPR1B | 0.30077950 |
137 | CSNK1A1 | 0.29932881 |
138 | ARAF | 0.29784596 |
139 | MAP3K10 | 0.29172503 |
140 | PRKACA | 0.29096993 |
141 | IKBKE | 0.28812823 |
142 | MAPK13 | 0.28601682 |
143 | PRKCA | 0.27348344 |
144 | MARK1 | 0.26877898 |
145 | DAPK3 | 0.26719586 |
146 | IRAK2 | 0.25863157 |
147 | MAP2K2 | 0.25795630 |
148 | GRK1 | 0.24937671 |
149 | SGK1 | 0.24539325 |
150 | GRK7 | 0.22140502 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Parkinsons disease_Homo sapiens_hsa05012 | 6.88921061 |
2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.15287772 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.46456514 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.31855973 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15473330 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.91373835 |
7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.78018987 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74246593 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.70455927 |
10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69855401 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.50676033 |
12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.37633964 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.36848142 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.36465142 |
15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.35908272 |
16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.20119221 |
17 | * Peroxisome_Homo sapiens_hsa04146 | 2.09557287 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.02164610 |
19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97839526 |
20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96624576 |
21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90989691 |
22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78526823 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78007707 |
24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74545234 |
25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.73335130 |
26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72245121 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.70067022 |
28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67994113 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64385746 |
30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61202379 |
31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.57697777 |
32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56429975 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55249509 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55189379 |
35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51488545 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47938990 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.45892153 |
38 | Bile secretion_Homo sapiens_hsa04976 | 1.44112418 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.43056599 |
40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41843708 |
41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.39922894 |
42 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39579898 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36950134 |
44 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.34865659 |
45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26447135 |
46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23898263 |
47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17521137 |
48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17483533 |
49 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.14696260 |
50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14051739 |
51 | ABC transporters_Homo sapiens_hsa02010 | 1.10633855 |
52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08865401 |
53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01173116 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00623964 |
55 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96612886 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87508681 |
57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85201663 |
58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84942489 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.84932864 |
60 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84319998 |
61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84142720 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83825827 |
63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80663350 |
64 | Lysine degradation_Homo sapiens_hsa00310 | 0.80464065 |
65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.78740114 |
66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73637426 |
67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66643562 |
68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.62293740 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56829820 |
70 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56619488 |
71 | Protein export_Homo sapiens_hsa03060 | 0.53514316 |
72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51296916 |
73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46618399 |
74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39627666 |
75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39383881 |
76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.38837658 |
77 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37708252 |
78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35260257 |
79 | Prion diseases_Homo sapiens_hsa05020 | 0.32554965 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.31590480 |
81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31094057 |
82 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26155911 |
83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26018261 |
84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25263598 |
85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21155561 |
86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20138093 |
87 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.19033552 |
88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17676658 |
89 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15665166 |
90 | Insulin secretion_Homo sapiens_hsa04911 | 0.12401706 |
91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.11835797 |
92 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.09610475 |
93 | Proteasome_Homo sapiens_hsa03050 | 0.09605774 |
94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09335611 |
95 | Lysosome_Homo sapiens_hsa04142 | -0.1936603 |
96 | Mineral absorption_Homo sapiens_hsa04978 | -0.1932391 |
97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1916986 |
98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1873241 |
99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1838203 |
100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.1753653 |
101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1585543 |
102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1382365 |
103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1334625 |
104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1184060 |
105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1183284 |
106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1102269 |
107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1094458 |
108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0689854 |
109 | Alzheimers disease_Homo sapiens_hsa05010 | -0.0570621 |
110 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0382768 |
111 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0353945 |
112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0154473 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0099446 |